Tci Wealth Advisors, Inc. Alnylam Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$182.66 - $235.53 $1,643 - $2,119	9 Added 31.03%	38 $7,000
Q4 2022 Feb 06, 2023	BUY	$185.53 - $241.31 $4,638 - $6,032	25 Added 625.0%	29 $6,000
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $138 - $232	1 Added 33.33%	4 $1,000
Q1 2022 Apr 29, 2022	SELL	$127.18 - $173.91 $127 - $173	-1 Reduced 25.0%	3 $0
Q4 2021 Jan 24, 2022	SELL	$159.56 - $209.29 $5,584 - $7,325	-35 Reduced 89.74%	4 $1,000
Q3 2021 Oct 29, 2021	BUY	$169.75 - $207.73 $6,111 - $7,478	36 Added 1200.0%	39 $7,000
Q2 2021 Aug 02, 2021	SELL	$128.63 - $176.89 $2,701 - $3,714	-21 Reduced 87.5%	3 $1,000
Q1 2021 Apr 29, 2021	BUY	$126.83 - $175.69 $2,409 - $3,338	19 Added 380.0%	24 $3,000
Q2 2020 Jul 20, 2020	SELL	$104.21 - $156.44 $1,042 - $1,564	-10 Reduced 66.67%	5 $1,000
Q1 2020 Apr 14, 2020	BUY	$93.12 - $133.99 $465 - $669	5 Added 50.0%	15 $2,000
Q4 2019 Jan 27, 2020	SELL	$74.51 - $124.23 $74 - $124	-1 Reduced 9.09%	10 $1,000
Q2 2019 Jul 23, 2019	SELL	$65.86 - $92.79 $526 - $742	-8 Reduced 42.11%	11 $1,000
Q1 2019 Apr 11, 2019	BUY	$72.76 - $93.45 $582 - $747	8 Added 72.73%	19 $2,000
Q4 2018 Jan 17, 2019	SELL	$62.67 - $88.33 $438 - $618	-7 Reduced 38.89%	11 $1,000
Q3 2018 Nov 02, 2018	BUY	$87.52 - $122.67 $612 - $858	7 Added 63.64%	18 $2,000
Q2 2017 Aug 10, 2017	BUY	N/A	11	11 $1,000

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.